Claire Sears


Claire Sears is the Director, Site Identification & Feasibility, IQVIA Technologies. Claire firmly believes closer relationships between investigators, sites and industry can bring great benefits to the clinical trial process. Prior to IQVIA Technologies, Claire worked for AstraZeneca in their clinical and commercial departments in scientific communications and medical affairs roles on products in all phases of development across several therapy areas. Claire has a background in scientific research, with a Doctorate in cardiovascular research.